Multiple genetic variants associated with posttransplantation diabetes mellitus in Chinese Han populations

Multiple genetic variants associated with posttransplantation diabetes mellitus in Chinese Han... AbbreviationsATadipose tissueBUNurea nitrogenCHOLcholesterolCNIcalcineurin inhibitorGLUglucoseGWASgenome‐wide association studiesHbA1Cglycosylated hemoglobin A1CHCChepatocellular carcinomaHLAhuman leukocyte antigenHRMhigh‐resolution meltingICDinternational classification of diseasesIL28Binterleukin 28BIP‐10interferon‐inducible protein 10IRSinsulin receptor substrateISGsIFN‐stimulated genesMCP‐1monocyte chemoattractant protein‐1MFImedian fluorescence intensityMIP‐1bmacrophage inflammatory protein‐1 betaPTDMposttransplantation diabetes mellitusSA‐PEstreptavidin‐phycoerythrinSNPssingle nucleotide polymorphismsSOCSsuppressor of cytokine signalingSTAT4signal transducer and activator of transcription 4TGtriglycerideINTRODUCTIONPosttransplantation diabetes mellitus (PTDM) is a frequent complication in patients treated with the immunosuppressive calcineurin inhibitor tacrolimus (Tac; FK506). Approximately 30%‐40% of liver transplant recipients have sustained diabetes beyond 6 months after transplant. The true prevalence of insulin resistance in patients after liver transplantation is unknown but presumed to be even greater. It is important to find biological markers that can predict the risk of PTDM; this could also provide new ideas for individualized therapies. Recent studies have identified single nucleotide polymorphisms (SNPs) associated with PTDM risk among Tac‐treated patients. It has been suggested that genotyping diabetes‐related polymorphisms could be a possible method of predicting a patient's risk for developing PTDM, and this information could be a valuable asset in the selection of appropriate immunosuppressive regimens.Posttransplantation diabetes mellitus is characterized by a combination of insulin resistance and insulin hyposecretion in liver transplant recipients. It has been reported that there is a particularly high prevalence of insulin resistance associated with viral http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Laboratory Analysis Wiley

Multiple genetic variants associated with posttransplantation diabetes mellitus in Chinese Han populations

Loading next page...
 
/lp/wiley/multiple-genetic-variants-associated-with-posttransplantation-diabetes-3J1iMtzvtr
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Wiley Periodicals, Inc.
ISSN
0887-8013
eISSN
1098-2825
D.O.I.
10.1002/jcla.22308
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsATadipose tissueBUNurea nitrogenCHOLcholesterolCNIcalcineurin inhibitorGLUglucoseGWASgenome‐wide association studiesHbA1Cglycosylated hemoglobin A1CHCChepatocellular carcinomaHLAhuman leukocyte antigenHRMhigh‐resolution meltingICDinternational classification of diseasesIL28Binterleukin 28BIP‐10interferon‐inducible protein 10IRSinsulin receptor substrateISGsIFN‐stimulated genesMCP‐1monocyte chemoattractant protein‐1MFImedian fluorescence intensityMIP‐1bmacrophage inflammatory protein‐1 betaPTDMposttransplantation diabetes mellitusSA‐PEstreptavidin‐phycoerythrinSNPssingle nucleotide polymorphismsSOCSsuppressor of cytokine signalingSTAT4signal transducer and activator of transcription 4TGtriglycerideINTRODUCTIONPosttransplantation diabetes mellitus (PTDM) is a frequent complication in patients treated with the immunosuppressive calcineurin inhibitor tacrolimus (Tac; FK506). Approximately 30%‐40% of liver transplant recipients have sustained diabetes beyond 6 months after transplant. The true prevalence of insulin resistance in patients after liver transplantation is unknown but presumed to be even greater. It is important to find biological markers that can predict the risk of PTDM; this could also provide new ideas for individualized therapies. Recent studies have identified single nucleotide polymorphisms (SNPs) associated with PTDM risk among Tac‐treated patients. It has been suggested that genotyping diabetes‐related polymorphisms could be a possible method of predicting a patient's risk for developing PTDM, and this information could be a valuable asset in the selection of appropriate immunosuppressive regimens.Posttransplantation diabetes mellitus is characterized by a combination of insulin resistance and insulin hyposecretion in liver transplant recipients. It has been reported that there is a particularly high prevalence of insulin resistance associated with viral

Journal

Journal of Clinical Laboratory AnalysisWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off